UK national chronic hypoparathyroidism audit.

Area of Science:

• Endocrinology
• Internal Medicine
• Nephrology

Background:

• Chronic hypoparathyroidism management can be suboptimal, leading to frequent hospitalizations and iatrogenic harm.
• European Society for Endocrinology (ESE) published consensus guidelines in 2015 for chronic hypoparathyroidism management.

Purpose of the Study:

• To audit compliance with the 2015 ESE guidelines for chronic hypoparathyroidism management in the United Kingdom.
• To identify areas of weakness in treatment and monitoring standards.

Main Methods:

• A national audit was conducted involving 117 UK endocrine departments.
• Data were collected from 22 departments on 80 patients regarding treatment and monitoring standards, hospitalizations, and Quality of Life.

Main Results:

• Post-surgical hypoparathyroidism was the most common cause (66.3%).
• Compliance with treatment standards ranged from 60% to 98.8%, while monitoring standards compliance varied from 20% to 91.3%.
• Key areas for improvement include 24-hour urinary calcium monitoring, serum magnesium monitoring, and renal imaging; 16.3% of patients had hospital admissions.

Conclusions:

• Further improvements in the national standard of care for chronic hypoparathyroidism in the UK are necessary.
• Enhancing management will benefit patient quality of life, reduce morbidity, and potentially impact mortality.